BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from −10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CRESY
Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria
There isn't enough reported data to score CRESY yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CRESY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Under pressure |
CRESY's profitability is currently strong, but its balance sheet is under pressure. There isn't enough data to rate its revenue and cash flow.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CRESY in the historical PE scenario, which offers more potential upside but is not a forecast.
CRESY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9.1x | $8.95 | — |
| Cheap | 9.5x | $0.95 | -89% |
| Fair | 11x | $1.05 | -88% |
| Expensive | 11x | $1.13 | -87% |
Historical ranges are pointers, not guarantees.
CRESY's PE is 9.1x, but its earnings don't support one, so it isn't a reliable read right now.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CRESY Forward outlook
There aren't enough analyst estimates for CRESY to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CRESY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | $0.10 | +25% |
| Q2 2024 | $0.08 | -90% |
| Q2 2023 | $0.82 | +257% |
CRESY has the edge over BA in the latest year-over-year earnings comparison.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
CRESY has the stronger quarterly revenue trend. Revenue is up 3.9% for BA versus up 804% for CRESY.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CRESY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $591.7M | +29% |
| Q2 2024 | $460.4M | +790% |
| Q1 2023 | $71.1M | +250% |
| Q4 2022 | $65.4M | +205% |
| Q3 2022 | $46.1M | +126% |
| Q2 2021 | $27.5M | -65% |
| Q2 2020 | $78.5M | +47% |
| Q2 2019 | $53.5M | +112% |
CRESY's revenue has grown year over year for six quarters in a row: $592M last quarter, up 804% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | 32% | +82 points |
| Q2 2024 | 4.5% | +6.8 points |
| Q2 2023 | -2.9% | N/A |
| Q1 2023 | 9.1% | +200 points |
| Q4 2022 | -50% | -268 points |
| Q3 2022 | -2.3% | +14 points |
| Q1 2022 | -191% | -227 points |
| Q4 2021 | 218% | +230 points |
CRESY's operating margin was 32% last quarter, up 82 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
CRESY has the stronger cash trend. Its trailing FCF is up 2,658% versus its history, compared with BA at up 100%.
CRESY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $68.3M | +$74.7M |
| Q2 2024 | -$6.3M | -146% |
| Q2 2023 | $13.9M | +780% |
| Q1 2023 | $5.3M | +$6M |
| Q4 2022 | -$21.1M | -2634% |
| Q3 2022 | $5.7M | -41% |
| Q2 2017 | $1.3M | +126% |
CRESY's free cash flow has turned positive again: $81M over the past year, against −$14M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over CRESY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CRESY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3% | +18.2M shares |
| 1 year | +811% | +560M shares |
| 3 years | +1043% | +574M shares |
CRESY has 629M diluted shares, up 811% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | $935,922 |
| Q1 2023 | $9.6M |
| Q4 2022 | $1.6M |
| Q3 2022 | $2.4M |
| Q2 2022 | $77,023 |
| Q1 2022 | $20,065 |
| Q4 2021 | $3,009 |
| Q3 2021 | $3,009 |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CRESY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | 3.2x | Elevated |
| Q2 2024 | 11.0x | High |
| Q2 2023 | 11.9x | High |
| Q1 2023 | 2.5x | Moderate |
| Q3 2022 | 1.6x | Healthy |
| Q2 2022 | 3.9x | Elevated |
| Q2 2021 | 6.8x | High |
| Q2 2020 | 5.1x | High |
CRESY's net debt is about 3.2 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CRESY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 9.8 | Oversold |
CRESY's weekly RSI is 33 (neutral) and its Stochastic is 10 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
CRESY PE vs Industrials Sector
| Metric | CRESY | Sector median | Relative |
|---|---|---|---|
| PE | 9.1x | 24x | 62% below |
| PE % | 10 | 58 | 48 pts below |
CRESY has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CRESY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.9 | 18% below |
| 20 week MA | $11.2 | 20% below |
| 50 week MA | $11.5 | 22% below |
| 100 week MA | $11.3 | 21% below |
| 200 week MA | $9.70 | 7.7% below |
CRESY is in a downtrend: it's below all five of its weekly moving averages, and 7.7% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over CRESY on returns for 2026, with the stronger performance.
CRESY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.05 | $3.82 | -46% |
| 2021 | $3.82 | $4.56 | +19% |
| 2022 | $4.56 | $5.93 | +30% |
| 2023 | $5.93 | $9.40 | +59% |
| 2024 | $9.40 | $12.9 | +37% |
| 2025 | $12.9 | $11.8 | -7.9% |
| 2026 YTD | $11.8 | $8.95 | -24% |
CRESY has finished higher in four of the last six years. It's down 24% so far in 2026.